Pilot Projects Program

COCVD第三阶段试点项目计划的主要目标是在基础上建立和扩大 通过为有价值的先导研究提供短期资金来推动发展，这些研究侧重于将肥胖作为 人类疾病。与我们机构确定的生物医学研究优势领域并行工作， 该计划将强调支持研究肥胖和肥胖之间关系的试点项目 心血管疾病、2型糖尿病、癌症和神经退行性疾病。该计划将支持 为初级/新研究人员研究肥胖是人类疾病的风险因素的研究，已建立 将肥胖作为风险因素纳入其疾病专业领域的研究人员，以及 提交方案赠款申请的多学科调查组。关于以下方面的决定 在项目第一阶段和第二阶段期间，COCVD成员将进行NIH格式审查后提供支持， 由具有特定专业知识(例如癌症)的成员补充。最初的科学功绩审查将是 提交给内部科学咨询委员会进行初步排名确定，然后是 外部咨询委员会对其进行审查和提供意见。试点项目资助金为期一年(5万美元) 第二年视进展而定。该方案迄今在运行和功能上取得的成功 将进入COCVD的第三阶段。

The primary objective of the Phase III Pilot Project Program of the COCVD is to build upon and expand momentum by providing short-term funding for meritorious pilot studies that focus on obesity as a risk factor for human diseases. Working in parallel with identified areas of biomedical research strength at our institution, the program will emphasize support for pilot projects that examine the relationship between obesity and cardiovascular diseases, type 2 diabetes, cancer and neurodegenerative diseases. The Program will support studies for junior/new investigators to study obesity as a risk factor for human diseases, established investigators who include obesity as a risk factor within their area of disease specialization, and multidisciplinary teams of investigators for submission of programmatic grant applications. Decisions on support will follow NIH-format review by members of the COCVD during Phase I and II of the program, supplemented by members with specific expertise (e.g., cancer). Initial scientific merit reviews will be submitted to the Internal Scientific Advisory Committee for initial ranking determinations, followed by the External Advisory Committee for their review and input. Pilot Project grants are designed for 1 year ($50,000) with a second year contingent upon progress. The successes of the program to date in operation and function will carry into Phase III of the COCVD.